KMTS
KMTS
NASDAQ · Health Care

Kestra Medical Technologies

$30.50
+1.49 (+5.14%)
As of Nov 7, 1:49 AM ET ·
Financial Highlights (FY 2026)
Revenue
97.81M
Net Income
-135,325,414
Gross Margin
51.4%
Profit Margin
-138.4%
Rev Growth
+131.9%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 51.4% 51.6% 51.6% 51.6%
Operating Margin -141.6% 19.2% 19.0% 18.4%
Profit Margin -138.4% 13.2% 16.0% 14.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 97.81M 467.86M 451.21M 384.70M
Gross Profit 50.25M 241.42M 232.82M 198.50M
Operating Income -138,541,925 89.79M 85.79M 70.89M
Net Income -135,325,414 61.58M 72.02M 57.24M
Gross Margin 51.4% 51.6% 51.6% 51.6%
Operating Margin -141.6% 19.2% 19.0% 18.4%
Profit Margin -138.4% 13.2% 16.0% 14.9%
Rev Growth +131.9% +24.3% -1.3% +10.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 119.90M 164.83M 164.09M 153.25M
Total Equity 729.75M 1.08B 950.20M 957.14M
D/E Ratio 0.16 0.15 0.17 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -129,592,373 118.92M 127.55M 105.65M
Free Cash Flow — 46.82M 46.49M 55.42M